Patient-reported outcomes in a randomized trial of everolimus with metastatic renal cell carcinoma patients

被引:0
|
作者
Beaumont, J.
Cella, D.
Hutson, T.
Bracarda, S.
Gruenwald, V.
Thompson, J.
Ravaud, A.
Urbanowitz, G.
Hollaender, N.
Motzer, R.
机构
[1] Ctr Outcomes Res & Educ, Evanston, IL USA
[2] Ctr Outcomes Res & Educ, Chicago, IL USA
[3] US Oncol, Baylor Sammons Canc Ctr, Dallas, TX USA
[4] Azienda Osped, Perugia, Italy
[5] Hannover Med Sch, D-3000 Hannover, Germany
[6] Canc Care Alliance, Seattle, WA USA
[7] CHU Bordeaux, Hop St Andre, Bordeaux, France
[8] Novartis, Oncol, Florham Pk, NJ USA
[9] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17516
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
    Castellano, D.
    Garcia del Muro, X.
    Perez-Gracia, J. L.
    Gonzalez-Larriba, J. L.
    Abrio, M. V.
    Ruiz, M. A.
    Pardo, A.
    Guzman, C.
    Diaz Cerezo, S.
    Grande, E.
    ANNALS OF ONCOLOGY, 2009, 20 (11) : 1803 - 1812
  • [32] Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial
    Denize, Thomas
    Farah, Subrina
    Cimadamore, Alessia
    Flaifel, Abdallah
    Walton, Emily
    Sticco-Ivins, Maura A.
    Labaki, Chris
    Braun, David A.
    Sun, Maxine
    Wang, Evelyn
    Xie, Wanling
    Choueiri, Toni K.
    Signoretti, Sabina
    CLINICAL CANCER RESEARCH, 2022, 28 (04) : 748 - 755
  • [33] Individualizing the Oncological Treatment of Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study
    Rasmussen, Ida Marie Lind
    Soerensen, Anne Vest
    Moller, Anne Kirstine
    Persson, Gitte Fredberg
    Palshof, Jesper Andreas
    Taarnhoj, Gry Assam
    Pappot, Helle
    JMIR RESEARCH PROTOCOLS, 2022, 11 (09):
  • [34] Sequential treatment of metastatic Renal cell carcinoma Everolimus in Therapy of metastatic Renal cell carcinoma
    Gschwend, Juergen E.
    AKTUELLE UROLOGIE, 2011, 42 (03) : A4 - A5
  • [35] Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial
    Staehler, M.
    Motzer, R. J.
    George, D. J.
    Pandha, H. S.
    Donskov, F.
    Escudier, B.
    Pantuck, A. J.
    Patel, A.
    DeAnnuntis, L.
    Bhattacharyya, H.
    Ramaswamy, K.
    Zanotti, G.
    Lin, X.
    Lechuga, M.
    Serfass, L.
    Paty, J.
    Ravaud, A.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2098 - 2104
  • [36] Immunomodulatory Effects of Everolimus in a Long Responsive Patient With Metastatic Renal Cell Carcinoma
    Thiery-Vuillemin, Antoine
    Laheurte, Caroline
    Mansi, Laura
    Royer, Bernard
    Pivot, Xavier
    Borg, Christophe
    Adotevi, Olivier
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (01) : 51 - 54
  • [38] Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    Ki Hyang Kim
    Sang Hyun Yoon
    Hae-Jung Lee
    Hyo Song Kim
    Sang Joon Shin
    Joong Bae Ahn
    Sun Young Rha
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 853 - 860
  • [39] Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    Kim, Ki Hyang
    Yoon, Sang Hyun
    Lee, Hae-Jung
    Kim, Hyo Song
    Shin, Sang Joon
    Ahn, Joong Bae
    Rha, Sun Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 853 - 860
  • [40] Patient-Reported Outcomes and Patient-Reported Experience of Patients With Atrial Fibrillation in the IMPACT-AF Clinical Trial
    Humphries, Brittany
    Cox, Jafna L.
    Parkash, Ratika
    Thabane, Lehana
    Foster, Gary A.
    MacKillop, James
    Nemis-White, Joanna
    Hamilton, Laura
    Ciaccia, Antonio
    Choudhri, Shurjeel H.
    Xie, Feng
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (15):